Red Tree Venture Capital

As a dedicated life science venture firm, Red Tree employs a West Coast-centric, early stage-biased investment strategy. We focus primarily on entrepreneurs developing first-in-class and/or best-in-class therapeutics addressing significant unmet needs in the areas of oncology, neurology, and immunology. We are deeply connected to the West Coast life science ecosystem with unique access to scientific luminaries and serial entrepreneurs at the region’s premier academic and research institutions. The strong relationships we have cultivated with our board of renowned and uniquely engaged scientific advisors allow us early access for sourcing the most promising innovation from these biotech hotbeds.